1. TFCP2/TFCP2L1/UBP1 transcription factors in cancer
   Grzegorz Kotarba et al, 2018, Cancer Letters CrossRef
2. Metformin disrupts malignant behavior of oral squamous cell carcinoma via a novel signaling involving Late SV40 factor/Aurora-A
   Chang-Han Chen et al, 2017, Sci Rep CrossRef
3. Diagnostic and prognostic relevance of CP2c and YY1 expression in hepatocellular carcinoma
   Ji Sook Kim et al, 2017, Oncotarget CrossRef
4. Epithelioid and spindle cell rhabdomyosarcoma with FUS-TFCP2 or EWSR1-TFCP2 fusion: report of two cases
   John S.A. Chrisinger et al, 2020, Virchows Arch CrossRef
5. High expression of tumor susceptibility gene 101 (TSG101) is associated with more aggressive behavior in colorectal carcinoma
   Elmira Gheytanchi et al, 2021, J Cancer Res Clin Oncol CrossRef
6. Pharmacological manipulation of LSF suppresses Wnt signaling and inhibits growth of allogeneic and syngeneic colon cancer xenografts
   Saran Lotfollahzadeh et al, 2022, The American Journal of Pathology CrossRef
7. Prognostic Implication of YY1 and CP2c Expression in Patients with Primary Breast Cancer
   Chihwan David Cha et al, 2023, Cancers CrossRef
8. TFCP2 as a therapeutic nexus: unveiling molecular signatures in cancer
   Neha Kaushik et al, 2024, Cancer Metastasis Rev CrossRef
9. Analysis of the Expression of LSF Transcription Factor in the Regulation of Transcription and TSG101 during the Neoplastic Transformation of Endometrial Cells
   Rafał Ziemiński et al, 2024, Cells CrossRef
10. Binding of Peptides Containing D‐Amino Acids to the Tsg101 Tumor Susceptibility Protein
    Hugo Perez et al, 2024, ChemistrySelect CrossRef